Treatment of Peri-Implant Mucositis With Standard of Care and Bioptron Hyperlight Therapy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 7, 2020

Primary Completion Date

January 10, 2021

Study Completion Date

January 13, 2022

Conditions
Mucositis OralDental Implant Failed
Interventions
DEVICE

Photobiomodulation with Bioptron Hyperlight Therapy

The Bioptron® Device provides polarized visible polychromatic noncoherent light with 90 W; light wavelength = 480-3400 nm; degree of polarization = 95%; specific power = 40 mW/cm2; energy density = 2.4 J/cm2. The duration of each treatment session was 10 min. Bioptron light was positioned 10 cm from the oral mucosa and a mouth opener was positioned for the entire duration of the session. Two weekly sessions during the first 4 weeks of treatment were applied.

Trial Locations (1)

70121

Roberto Felice Grassi, Bari

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT05307445 - Treatment of Peri-Implant Mucositis With Standard of Care and Bioptron Hyperlight Therapy | Biotech Hunter | Biotech Hunter